Literature DB >> 7650367

Expression of Bcl-2, Bcl-x, and Bax after T cell activation and IL-2 withdrawal.

H E Broome1, C M Dargan, S Krajewski, J C Reed.   

Abstract

Bcl-2, bcl-x, and bax genes code for proteins that affect the susceptibility of cells to apoptosis. In general, the expression of bcl-2 or bcl-x inhibits apoptosis while bax promotes apoptosis. We examined the levels of these proteins by immunoblotting in resting and activated T cells and in thymocytes. Bcl-2 and Bax proteins vary coordinately, but Bcl-x varies independently: Bcl-2 and Bax are higher in splenic T cells than in thymocytes, and their levels increase even more after T cell activation. In contrast, Bcl-x is almost undetectable in splenic T cells but is manyfold greater in thymocytes and in activated splenic T cells. When CTLL-2 cells or activated T cells are starved of IL (IL-2), the level of Bcl-x but not Bcl-2 protein drops before the onset of apoptosis. Stable transfection of either bcl-2 or bcl-x expression plasmids promotes the survival of CTLL-2 cells in the setting of IL-2 withdrawal. Over 70 to 90% of the transfected cells remain viable at 48 h after IL-2 withdrawal when all of the control transfected cells are apoptotic. These findings suggest that a decrease in Bcl-x protein levels precedes apoptosis after IL-2 withdrawal in T cells and that transfected bcl-2 promotes survival after IL-2 withdrawal by functionally masking this drop in Bcl-x.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7650367

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  30 in total

Review 1.  The functions of cytokines and their uses in toxicology.

Authors:  J R Foster
Journal:  Int J Exp Pathol       Date:  2001-06       Impact factor: 1.925

2.  Demethylating agent 5-aza-2-deoxycytidine enhances susceptibility of breast cancer cells to anticancer agents.

Authors:  Sameer Mirza; Gayatri Sharma; Pranav Pandya; Ranju Ralhan
Journal:  Mol Cell Biochem       Date:  2010-05-09       Impact factor: 3.396

3.  CCR5 blockade is well tolerated and induces changes in the tissue distribution of CCR5+ and CD25+ T cells in healthy, SIV-uninfected rhesus macaques.

Authors:  Jessica E Taaffe; Steven E Bosinger; Gregory Q Del Prete; James G Else; Sarah Ratcliffe; Christopher D Ward; Thi Migone; Mirko Paiardini; Guido Silvestri
Journal:  J Med Primatol       Date:  2011-11-14       Impact factor: 0.667

4.  CD3 hyporesponsiveness and in vitro apoptosis are features of T cells from both malignant and nonmalignant secondary lymphoid organs.

Authors:  S Agrawal; J Marquet; M H Delfau-Larue; C Copie-Bergman; H Jouault; F Reyes; A Bensussan; J P Farcet
Journal:  J Clin Invest       Date:  1998-11-01       Impact factor: 14.808

5.  A novel Bcl-x isoform connected to the T cell receptor regulates apoptosis in T cells.

Authors:  X F Yang; G F Weber; H Cantor
Journal:  Immunity       Date:  1997-11       Impact factor: 31.745

6.  Inflammescent CX3CR1+CD57+CD8+ T cells are generated and expanded by IL-15.

Authors:  Stephen R Morris; Bonnie Chen; Joseph C Mudd; Soumya Panigrahi; Carey L Shive; Scott F Sieg; Cheryl M Cameron; David A Zidar; Nicholas T Funderburg; Souheil-Antoine Younes; Benigno Rodriguez; Sara Gianella; Michael M Lederman; Michael L Freeman
Journal:  JCI Insight       Date:  2020-06-04

7.  Bcl-3 expression promotes cell survival following interleukin-4 deprivation and is controlled by AP1 and AP1-like transcription factors.

Authors:  A Rebollo; L Dumoutier; J C Renauld; A Zaballos; V Ayllón; C Martínez-A
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

8.  Selective regulation of Bcl-XL by a Jak kinase-dependent pathway is bypassed in murine hematopoietic malignancies.

Authors:  G Packham; E L White; C M Eischen; H Yang; E Parganas; J N Ihle; D A Grillot; G P Zambetti; G Nuñez; J L Cleveland
Journal:  Genes Dev       Date:  1998-08-15       Impact factor: 11.361

9.  T cell apoptosis in human heart allografts: association with lack of co-stimulation?

Authors:  E Van Hoffen; D F Van Wichen; J C Leemans; R A Broekhuizen; A H Bruggink; M De Boer; N De Jonge; H Kirkels; P J Slootweg; F H Gmelig-Meyling; R A De Weger
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

10.  Death pathways in T cell homeostasis and their role in autoimmune diabetes.

Authors:  Matthew A Gronski; Michael Weinem
Journal:  Rev Diabet Stud       Date:  2006-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.